Skip to main content
NACFC 2025 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Session includes an in person invitee/speaker with CF
Session includes an in person invitee/speaker with CF
Livestreamed Session
Livestreamed Session
Recorded Session
Recorded Session
Session is Ticketed (Must Register for Session through Registration)
Session is Ticketed (Must Register for Session through Registration)
Food Available for Session Attendees
Food Available for Session Attendees

Steven Rowe, MD MSPH

Cystic Fibrosis Foundation

Dr. Steven Rowe, MD, MSPH, is the Executive Vice President and Chief Scientific Officer for the Cystic Fibrosis Foundation, where he leads the Foundation’s scientific strategy, including efforts to develop new therapies for CF. He is also a Professor at the University of Alabama at Birmingham School of Medicine, where he directs a translational research laboratory focusing on cystic fibrosis.
Dr. Rowe’s pioneering work in cystic fibrosis has shaped the development of CFTR modulators, therapies that treat the underlying cause of CF. He has led or co-led numerous national and international clinical trials, including the landmark GOAL, PROSPECT, and PROMISE studies, which have transformed CF care and personalized therapy. Dr. Rowe is also a leader in genetic therapies for CF, having led national and international discovery efforts targeting CF nonsense mutations for which there are currently no approved therapies.
Dr. Rowe has authored over 280 peer-reviewed publications in top-tier journals including Nature, New England Journal of Medicine. Dr. Rowe is a member of the American Society of Clinical Investigation and the Association of American Physicians.

Presentation(s):